Congenital Diseases of the Heart: Clinical-Physiological Considerations

Congenital Diseases of the Heart: Clinical-Physiological Considerations

Volumn , Issue , 2009, Pages 1-538

  Rudolph, Abraham M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889265857     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444311822     Document Type: Book

References (468)

1. Bristow J, Rudolph AM, Itskovitz J. A preparation for studying liver blood flow, oxygen consumption, and metabolism in the fetal lamb in utero. J Dev Physiol 1981;3:255-266.
2. Lind J, Stern L, Wegelius C. Human Foetal and Neonatal Circulation. Springfield, IL: Charles C Thomas, 1964.
3. Edelstone DI, Rudolph AM, Heymann MA. Liver and ductus venosus blood flows in fetal lambs in utero. Circ Res 1978;42:426-433.
4. Bristow J, Rudolph AM, Itskovitz J, Barnes RJ. Hepatic oxygen and glucose metabolism in the fetal lamb: response to hypoxia. J Clin Invest 1983;71:1047-1061.
5. Edelstone DI, Rudolph AM. Preferential streaming of ductus venosus blood to the brain and heart in fetal lambs. Am J Physiol 1979;237:H724-H729.
6. Schmidt KG, Silverman NH, Rudolph AM. Assessment of flow events at the ductus venosus-inferior vena cava junction and at the foramen ovale in fetal sheep by use of multimodal ultrasound. Circulation 1996;93: 826-833.
7. Rudolph AM, Heymann MA, Teramo KAW, Barrett CT, Raiha NCR. Studies on the circulation of the previable human fetus. Pediatr Res 1971;5:452-465.
8. Reuss ML, Rudolph AM. Distribution and recirculation of umbilical and systemic venous blood flow in fetal lambs during hypoxia. J Dev Physiol 1980;2: 71-84.
9. Rudolph AM, Heymann MA. Circulatory changes with growth in the fetal lamb. Circ Res 1970;26:289-299.
10. Kenny J, Plappert T, Doubilet P et al. Changes in intracardiac blood flow velocities and right and left ventricular stroke volumes with gestational age in the normal human fetus: a prospective Doppler echocardiographic study. Circulation 1986;74:1208-1216.
11. De Smedt MCH, Visser GHA, Meijboom EJ. Fetal cardiac output estimated by Doppler echocardiography during mid-and late gestation. Am J Cardiol 1987;60: 338-342.
12. Sutton MS, Groves A, MacNeill A, Sharland G, Allan L. Assessment of changes in blood flow through the lungs and foramen ovale in the normal human fetus with gestational age: a prospective Doppler echocardiographic study. Br Heart J 1994;71:232-237.
13. Chaoui R, Heling KS, Taddei F, Bollmann R. Dopplerechokardiographische Analyse des Blutflusses über den fetalen Aorten und Pulmonalklappen in der zweiten Hälfte der Schwangerschaft. Geburtshilfe Frauenheilkd 1995;55:207-217.
14. Rasanen J, Wood DC, Weiner S, Ludomirski A, Huhta JC. Role of the pulmonary circulation in the distribution of the human fetal cardiac output during the second half of pregnancy. Circulation 1996;94:1068-1073.
15. Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. Circulation 2001;103:1662-1668.
16. Rasanen J, Wood DC, Debbs RH, Cohen J, Weiner S, Huhta JC. Reactivity of the human fetal pulmonary circulation to maternal hyperoxygenation increases during the second half of pregnancy: a randomized study. Circulation 1998;97:257-262.
17. Kiserud T, Ebbing C, Kessler J, Rasmussen S. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol 2006;28:126-136.
18. Dekaban AS, Sadowsky D. Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 1978; 4:345-356.
19. Behrman RE, Lees MH. Organ blood flows of the fetal, newborn and adult rhesus monkey: a comparative study. Biol Neonate 1971;18:330-334.
20. Acharya G, Wilsgaard T, Rosvold Berntsen GK, Maltau JM, Kiserud T. Reference ranges for umbilical vein blood flow in the second half of pregnancy based on longitudinal data. Prenat Diagn 2005;25:99-111.
21. Van Lierde M, Oberweis D, Thomas K. Ultrasonic measurement of aortic and umbilical blood flow in the human fetus. Obstet Gynecol 1984;63:801-805.
22. Haugen G, Kiserud T, Godfrey K, Crozier S, Hanson M. Portal and umbilical venous blood supply to the liver in the human fetus near term. Ultrasound Obstet Gynecol 2004;24:599-605.
23. Rudolph AM, Heymann MA. The circulation of the fetus in utero. Circ Res 1967;21:163-184.
24. Kessler J, Rasmussen S, Hanson M, Kiserud T. Longitudinal reference ranges for ductus venosus flow velocities and waveform indices. Ultrasound Obstet Gynecol 2006;28:890-898.
25. Rudolph AM, Heymann MA. Cardiac output in the fetal lamb: the effects of spontaneous and induced changes of heart rate on right and left ventricular output. Am J Obstet Gynecol 1976;124:183-192.
26. Gilbert RD. Control of fetal cardiac output during changes in blood volume. Am J Physiol 1980;238: H80-H86.
27. Hawkins J, Van Hare GF, Schmidt KG, Rudolph AM. Effects of increasing afterload on left ventricular output in fetal lambs. Circ Res 1989;65:127-134.
28. Friedman WF. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 1972;15: 87-111.
29. Mahony L, Jones LR. Developmental changes in cardiac sarcoplasmic reticulum in sheep. J Biol Chem 1986;261: 15257-15265.
30. Itskovitz J, LaGamma EF, Rudolph AM. Baroreflex control of the circulation in chronically instrumented fetal lambs. Circ Res 1983;52:589-596.
31. Shinebourne EA, Vapaavuori EK, Williams RL, Heymann MA, Rudolph AM. Development of baroreflex activity in unanesthetized fetal and neonatal lambs. Circ Res 1972;31:710-718.
32. Itskovitz J, Rudolph AM. Denervation of arterial chemoreceptors and baroreceptors in fetal lambs in utero. Am J Physiol 1982;242:H916-H920.
33. Boekkooi PF, Baan J Jr, Teitel D, Rudolph AM. Chemoreceptor responsiveness in fetal sheep. Am J Physiol 1992;263:H162-H167.
34. Brace RA. Effects of outflow pressure on fetal lymph flow. Am J Obstet Gynecol 1989;160:494-497.
35. Brace RA, Valenzuela GJ. Effects of outflow pressure and vascular volume loading on thoracic duct lymph flow in adult sheep. Am J Physiol 1990;258:R240-R244.
36. Fishman NH, Hof RB, Rudolph AM. Models of congenital heart disease in fetal lambs. Circulation 1978;58: 354-364.
37. Wild LM, Nickerson PA, Morin FC III. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 1989;25:251-257.
38. Abman SH, Shanley PF, Accurso FJ. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 1989;83:1849-1858.
39. Levin DL, Hyman AI, Heymann MA, Rudolph AM. Fetal hypertension and the development of increased pulmonary vascular smooth muscle: a possible mechanism for persistent pulmonary hypertension of the newborn infant. J Pediatr 1978;92:265-269.
40. Rudolph AM. Aortopulmonary transposition in the fetus: speculation on pathophysiology and therapy. Pediatr Res 2007;61:375-380.
41. Jouannic JM, Gavard L, Fermont L et al. Sensitivity and specificity of prenatal features of physiological shunts to predict neonatal clinical status in transposition of the great arteries. Circulation 2004;110:1743-1746.
42. Kaltman JR, Di H, Tian Z, Rychik J. Impact of congenital heart disease on cerebrovascular blood flow dynamics in the fetus. Ultrasound Obstet Gynecol 2005;25:32-96.
43. Teitel DF, Iwamoto HS, Rudolph AM. Effects of birthrelated events on central blood flow patterns. Pediatr Res 1987;22:557-566.
44. Teitel DF, Iwamoto HS, Rudolph AM. Changes in the pulmonary circulation during birth-related events. Pediatr Res 1990;27:372-378.
45. van Bel F, Roman C, Iwamoto HS, Rudolph AM. Sympathoadrenal, metabolic, and regional blood flow responses to cold in fetal sheep. Pediatr Res 1993;34:47-50.
46. Grant DA, Kondo CS, Maloney JE, Walker AM, Tyberg JV. Changes in pericardial pressure during the perinatal period. Circulation 1992;86:1615-1621.
47. Breall JA, Rudolph AM, Heymann MA. Role of thyroid hormone in postnatal circulatory and metabolic adjustments. J Clin Invest 1984;73:1418-1424.
48. Teitel DF, Sidi D, Chin T, Brett C, Heymann MA, Rudolph AM. Developmental changes in myocardial contractile reserve in the lamb. Pediatr Res 1985;19: 948-955.
49. Klopfenstein HS, Rudolph AM. Postnatal changes in the circulation and responses to volume loading in sheep. Circ Res 1978;42:839-845.
50. Adeagbo AS, Coceani F, Olley PM. The response of the lamb ductus venosus to prostaglandins and inhibitors of prostaglandin and thromboxane synthesis. Circ Res 1982;51:580-586.
51. Paulick RP, Meyers RL, Rudolph CD, Rudolph AM. Venous and hepatic vascular responses to indomethacin and prostaglandin E1 in the fetal lamb. Am J Obstet Gynecol 1990;163:1357-1363.
52. Townsend SF, Rudolph CD, Rudolph AM. Changes in ovine hepatic circulation and oxygen consumption at birth. Pediatr Res 1989;25:300-304.
53. Fisher DJ, Rudolph AM, Heymann MA. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am J Physiol 1980;238: H399-H405.
54. Friedman WF. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 1972;15:87-111.
55. Rudolph AM, Roman C, Gournay VA. Perinatal myocardial DNA and protein changes in the lamb: effect of cortisol in the fetus. Pediatr Res 1999;46:141-146.
56. Jonker SS, Zhang L, Louey S, Giraud GD, Thornburg KL, Faber JJ. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol 2007;102:1130-1142.
57. Levene M, Chiswick M, Field D et al. Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Arch Dis Child 1992;67:1221-1227.
58. Dempsey EM, Barrington KJ. Treating hypotension in the preterm infant: when and with what: a critical and systematic review. J Perinatol 2007;27:469-478.
59. Evans N. Assessment and support of the preterm circulation. Early Human Develop 2006;82:803-810.
60. Kluckow M, Evans N, Osborn DA. Low systemic blood flow and brain injury in the preterm infant. NeoReviews 2004;5:E98-E108.
61. Hawkins J, Van Hare GF, Schmidt KG, Rudolph AM. Effects of increasing afterload on left ventricular output in fetal lambs. Circ Res 1989;65:127-134.
62. Takahashi Y, Harada K, Kishkurno S, Arai, Ishida A, Takada G. Postnatal left ventricular contractility in very low birth weight infants. Pediatr Cardiol 1997;18: 112-117.
63. Clyman RI, Mauray F, Heymann MA, Roman C. Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress. J Pediatr 1987;111:579-587.
64. Paradisis M, Evans N, Kluckow M, Osborn D, McLachlan AJ. Pilot study of milrinone for low systemic blood flow in very preterm infants. J Pediatr 2006;148:306-313.
65. Van Slyke DP, Neill JM. The determination of gases in blood and other solutions by vacuum extraction and manometric measurement. J Biol Chem 1924;61:523.
66. Clauvel M, Schwartz K. Blood oxygen capacity. Technical difficulties of its determination by the Van Slyke method and comparison with hemoglobin content. Clin Chem 1968;14:253-261.
67. Toth B, Becker A, Seelbach-Göbel B. Oxygen saturation in healthy newborn infants immediately after birth measured by pulse oximetry. Am J Obstet Gynecol 2002;266:105-107.
68. Rabi Y, Yee W, Chen SY, Singhal N. Oxygen saturation trends immediately after birth. J Pediatr 2006;148:590-594.
69. Hamilton C, Steinlecher B, Gruber E, Simon P, Wollenek G. The oxygen dissociation curve: quantifying the shift. Perfusion 2004;19:141-144.
70. Sidi D, Kuipers JRG, Teitel D, Heymann MA, Rudolph AM. Developmental changes in oxygenation and circulatory responses to hypoxemia in lambs. Am J Physiol 1983;245:H674-H682.
71. Gournay VA, Roman C, Rudolph AM. Effect of betaadrenergic stimulation on oxygen metabolism in the fetal lamb. Pediatr Res 1999:45:432-436.
72. Ball KT, Gunn TR, Power GG, Asakura H, Gluckman PD. A potential role for adenosine in the inhibition of nonshivering thermogenesis in the fetal sheep. Pediatr Res 1995;37:303-309.
73. Bristow J, Rudolph AM, Itskovitz J, Barnes RJ. Hepatic oxygen and glucose metabolism in the fetal lamb: response to hypoxia. J Clin Invest 1983;71:1047-1061.
74. Sidi D, Kuipers JR, Heymann MA, Rudolph AM. Effects of ambient temperature on oxygen consumption and the circulation in newborn lambs at rest and during hypoxemia. Pediatr Res 1983;17:254-258.
75. Toubas PL, Hof RP, Heymann MA, Rudolph AM. Effects of hypothermia and rewarming on the neonatal circulation. Arch Franc Pediat (Suppl) 1978;34:84-92.
76. Itskovitz J, LaGamma EF, Rudolph AM. The effects of reducing umbilical blood flow on fetal oxygenation. Am J Obstet Gynecol 1983;145:813-818.
77. Fisher DJ, Rudolph AM, Heymann MA. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am J Physiol 1980;238: H399-H405.
78. Teisseire BP, Ropars C, Vallez MO, Herigault RA, Nicolau C. Physiological effects of high-P50 erythrocyte transfusion on piglets. J Appl Physiol 1985;58:1810-1817.
79. Cohn HE, Sacks EJ, Heymann MA, Rudolph AM. Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol 1974;120:817-824.
80. van Bel F, Sola A, Roman C, Rudolph AM. Role of nitric oxide in the regulation of the cerebral circulation in the lamb fetus during normoxemia and hypoxemia. Biol Neonate 1995;68:200-210.
81. Jensen A, Roman C, Rudolph AM. Effects of reducing uterine blood flow on fetal blood flow distribution and oxygen delivery. J Dev Physiol 1991;15:309-323.
82. Bartelds B, van Bel F, Teitel DF, Rudolph AM. Carotid, not aortic, chemoreceptors mediate the fetal cardiovascular response to acute hypoxemia in lambs. Pediatr Res 1993;34:51-55.
83. Thompson J, Moore P, Teitel DF. Pulmonary venous wedge pressures accurately predict pulmonary arterial pressures in children with single ventricle physiology. Pediatr Cardiol 2003;24:531-537.
84. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res 1970;4:23-30.
85. Lindahl SG. Oxygen consumption and carbon dioxide elimination in infants and children during anaesthesia and surgery. Br J Anaesth 1989;62:70-76.
86. Lundell BP, Casas ML, Wallgren CG. Oxygen consumption in infants and children during heart catheterization. Pediatr Cardiol 1996;17:207-213.
87. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 1951;4:1-29.
88. Hall SM, Hislop AA, Pierce CM, Haworth SG. Prenatal origins of human intrapulmonary arteries. Am J Respir Cell Mol Biol 2000;23:194-203.
89. Parera MC, van Dooren M, van Kempen M et al. Distal angiogenesis: a new concept for lung vascular morphogenesis. Am J Physiol 2005;288:L148-L149.
90. Jakkula M, Le Cras TD, Gebb S et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol 2000;279:L600-L607.
91. Thebaud B, Ladha F, Michelakis ED et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-2486.
92. Frid MG, Moiseeva EP, Stenmark KR. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 1994;75:669-681.
93. Webb S, Kanani M, Anderson RH, Richardson MK, Brown NA. Development of the human pulmonary vein and its incorporation in the morphological left atrium. Cardiol Young 2001;11:632-642.
94. Levin DL, Rudolph AM, Heymann MA, Phibbs RH. Morphological development of the pulmonary vascular bed in fetal lambs. Circulation 1976;53:144-151.
95. Wagenvoort CA, Neufeld HN, Edwards JE. The structure of the pulmonary arterial tree in fetal and early postnatal life. Lab Invest 1961;10:751-762.
96. Rudolph AM, Heymann MA. Circulatory changes with growth in the fetal lamb. Circ Res 1970;26:289-299.
97. Rasanen J, Wood DC, Debbs RH, Cohen J, Weiner S, Huhta JC. Reactivity of the human fetal pulmonary circulation to maternal hyperoxygenation increases during the second half of pregnancy: a randomized study. Circulation 1998;97:257-262.
98. Sutton MS, Groves A, MacNeill A, Sharland G, Allan L. Assessment of changes in blood flow through the lungs and foramen ovale in the normal human fetus with gestational age: a prospective Doppler echocardiographic study. Br Heart J 1994;71:232-237.
99. Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. Circulation 2001;103:1662-1668.
100. Cassin S, Dawes GS, Ross BB. Pulmonary blood flow and vascular resistance in immature foetal lambs. 1964;171: 80-89.
101. Heymann MA, Rudolph AM, Nies AS, Melmon KL. Bradykinin production association with oxygenation of the fetal lamb. Circ Res 1969;25:521-534.
102. Lewis AB, Heymann MA, Rudolph AM. Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res 1976;39:536-541.
103. Zhang F, Carson RC, Zhang H, Gibson G, Thomas HM. Pulmonary artery smooth muscle cell [Ca2+]i and contraction: responses to diphenyleneiodonium and hypoxia. Am J Physiol 1997;273:L603-L611.
104. Rudolph AM, Yuan S. (1966) Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest 45, 399-411.
105. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Edu 2003;27:201-206.
106. Chitaley K, Weber DS, Webb RC. RhoA/Rho-kinase, vascular changes and hypertension. Curr Hypertens Rep 2001;3:139-144.
107. Soifer SJ, Morin FC III, Kaslow DC, Heymann MA. The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb. J Dev Physiol 1983;5:237-250.
108. Jiallard S, Larrue B, Deruelle P et al. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb. Ann Thorac Surg 2006;81:935-942.
109. Fukumoto Y, Matoba T, Ito A et al. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart 2005;91:391-392.
110. Wong J, Fineman JR, Heymann. The role of endothelin and endothelin subtypes in regulation of fetal pulmonary vascular tone. Pediatr Res 1994;35:664-670.
111. Ivy DD, Parker TA, Ziegler JW et al. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 1997;99: 1179-1186.
112. Ivy DD, Parker TA, Kinsella JP, Abman SH. Endothelin A receptor blockade decreases pulmonary vascular resistance in premature lambs with hyaline membrane disease. Pediatr Res 1998;44:175-180.
113. Waypa GB, Chandel NS, Schumacker PT. Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 2001;88:1259-1266.
114. Kinsella JP, Parker TA, Davis JM, Abman SH. Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med 2005;172:745-749.
115. Abman SH, Accurso FJ. Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation. Am J Physiol 1989;257:H626-H634.
116. Levin DL, Hyman AI, Heymann MA, Rudolph AM. Fetal hypertension and the development of increased pulmonary vascular smooth muscle: a possible mechanism for persistent pulmonary hypertension of the newborn infant. J Pediatr 1978;92:265-269.
117. Ardran GM, Dawes GS, Prichard MML, Reynolds SRM, Wyatt DG. The effect of ventilation of the foetal lungs upon the pulmonary circulation. J Physiol 1952;118: 12-22.
118. Cassin S, Dawes GS, Mott JC, Ross BB, Strang LB. The vascular resistance of the foetal and newly ventilated lung of the lamb. J Physiol 1964;171:61-79.
119. Lauer RM, Evans JA, Aoki H, Kittle CF. Factors controlling pulmonary vascular resistance in fetal lambs. J Pediatr 1965;67:568-577.
120. Teitel DF, Iwamoto HS, Rudolph AM. Changes in the pulmonary circulation during birth-related events. Pediatr Res 1990;27:372-378.
121. Leffler CW, Hessler JR, Terragno NA. Ventilationinduced release of prostaglandinlike material from fetal lungs. Am J Physiol 1980;238:H282-H286.
122. Velvis H, Moore P, Heymann MA. Prostaglandin inhibition prevents the fall in pulmonary vascular resistance as a result of rhythmic distension of the lungs in fetal lambs. Pediatr Res 1991;30:52-58.
123. Moore P, Velvis H, Fineman JR, Soifer SJ, Heymann MA. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. J Appl Physiol 1992;73:2151-2157.
124. Ivy DD, Lee DS, Rairigh RL, Parker TA, Abman SH. Endothelin B receptor blockade attenuates pulmonary vasodilation in oxygen-ventilated fetal lambs. Biol Neonate 2004;86:155-159.
125. Post J, Hume J, Archer S, Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 1992;262:C882-C890.
126. Archer SL, Wu XC, Thébaud B et al. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 2004;95:308-318.
127. Staub NC, Storey WF. Relation between morphological and physiological events in lung studied by rapid freezing. J Appl Physiol 1962;17:381-390.
128. Haworth SG, Hall SM, Chew M, Allen K. Thinning of fetal pulmonary arterial wall and postnatal remodelling: ultrastructural studies on the respiratory unit arteries of the pig. Virchows Arch A Pathol Anat Histopathol 1987;411:161-171.
129. Hassoun PM, Thappa V, Landman JA, Fanburg BL. Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med 1992;199: 165-170.
130. Danilowicz DA, Rudolph AM, Hoffman JIE, Heymann MA. Physiologic pressure differences between main and branch pulmonary arteries in infants. Circulation 1972;45:410-419.
131. Holm P, Lisca J, Clozel M, Franco-Cereceda F. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs. J Thorac Cardiovasc Surg 1996;112:890-897.
132. Ruan Z, Koizumi T, Sakai A, Ishizaki T, Wang Z. Endogenous nitric oxide and pulmonary circulation response to hypoxia in high-altitude adapted Tibetan sheep. Eur J Appl Physiol 2004;93:190-195.
133. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 1998;274: L212-L219.
134. Rudolph AM, Auld PA, Golinko RJ, Paul MH. Pulmonary vascular adjustments in the neonatal period. Pediatrics 1961;28:28-34.
135. Durmowicz AG, Stenmark KR. Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev 1999;20:e91-e102.
136. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99:675-691.
137. Rabinovitch M, Konstam MA, Gamble WJ et al. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ Res 1983;52:432-441.
138. Rabinovitch M. EVE and beyond, retro and prospective insights. Am J Physiol 1999;277:5-12.
139. Reddy VM, Wong J, Liddicoat JR, Johengen M, Chang R, Fineman JR. (1996) Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 271, H562-H570.
140. Steinhorn, RH, Fineman JR. (1999) The pathophysiology of pulmonary hypertension in congenital heart disease. Artificial Organs 23, 970-974.
141. Fratz S, Geiger R, Kresse H, Roemer G, Henning M, Sebening W, Hess J. (2003) Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance. J Thorac Cardiovasc Surg 126, 1724-1729.
142. Adatia I, Haworth SG. (1993) Circulating endothelin in children with congenital heart disease. Brit Heart J 69, 233-236.
143. Rudoiph AM, Neuhauser EBD, Golinko RJ, Auld PAM. (1961) Effects of pneumonectomy on pulmonary circulation in adult and young animals. Circ Res 9, 856-861.
144. Wagenvoort CA, Wagenvoort N, Vogel JH. (1969) The pulmonary vasculature in cattle at an altitude of 1,600 metres with and without one-sided pulmonary arterial ligation. J Comp Pathol 79, 517-523.
145. Vogel JH, McNamara DG, Blount SG Jr. (1967) Role of hypoxia in determining pulmonary vascular resistance in infants with ventricular septal defects Am J Cardiol 20, 346-349.
146. Heath D, Edwards JE. (1958) The pathology of hypertensive pulmonary vascular disease; a description of six grades of strudtural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18, 533-547.
147. Fry DL. (2002) Arterial intimal-medial permeability and Coevolving structural responses to defined shear-stress exposures. Am J Physiol Heart Circ Physiol 283, H2341-H2355.
148. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Gen 67, 737-744.
149. Morse JH. (2002) Bone Morphogenetic Protein Receptor 2 Mutations in Pulmonary Hypertension. Chest 121, 50S-53S.
150. Roberts KE, McElroy JJ, Wong WPK, Yen E, Widlitz A, Barst RJ, Knowles JA, Morse JH. (2004) BMPR2 mutations in pulmonary arterial hypertension with congenital heart diseas. Eur Respir J 24, 371-374.
151. Rudolph AM, Paul MH, Sommer LS, Nadas AS. (1958) Effects of tolazoline hydrochloride (priscoline) on circulatory dynamics of patients with pulmonary hypertension. Am Heart J 55, 424-432.
152. Wimmer M, Schlemmer M. (1992) Long-term hemodynamic effects of nifedipine on congenital heart disease with Eisenmenger's mechanism in children. Cardiovasc Drugs Ther. 6, 183-186.
153. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M. (2006) Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 114, 48-54.
154. Rosenzweig EB, Kerstein D, Barst RJ. (1999) Long-term prostacyclin for pulmonary hypertension with associated with congenital heart defects. Circulation 99, 1858-65.
155. Baquero H, Soliz A, Neira F, Venegas ME, Sola A. (2006) Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics. 117, 1077-1083.
156. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin W. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest. 2007 131, 917-28.
157. Hoffman JIE. In: Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ, eds. Rudolph's Pediatrics. New York: McGraw-Hill, 2002: 1781.
158. Lloyd TR, Beekman RH III. Clinically silent patent ductus arteriosus [Letter]. Am Heart J 1994;127:1664-1665.
159. Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. Circulation 2001;103:1662-1668.
160. Sutton MS, Groves A, MacNeill A, Sharland G, Allan L. Assessment of changes in blood flow through the lungs and foramen ovale in the normal human fetus with gestational age: a prospective Doppler echocardiographic study. Br Heart J 1994;71:232-237.
161. Rasanen J, Wood DC, Weiner S, Ludomirski A, Huhta JC. Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy. Circulation 1996;94:1068-1073.
162. Shiraishi H, Yanagisawa M. Bidirectional flow through the ductus arteriosus in normal newborns: evaluation by Doppler color flow imaging. Pediatr Cardiol 1991;12: 201-205.
163. Clyman RI, Chan CY, Mauray F et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 1999;45:19-29.
164. Kennedy JA, Clark SL. Observations on the physiological reactions of the ductus arteriosus. Am J Physiol 1942;136: 140-144.
165. Oberhansli-Weiss I, Heymann MA, Rudolph AM, Melmon KL. The pattern and mechanisms of response of the ductus arteriosus and umbilical artery to oxygen. Pediatr Res 1972;6:693-700.
166. McMurphy DM, Heymann MA, Rudolph AM, Melmon KL. Developmental changes in constriction of the ductus arteriosus: responses to oxygen and vasoactive substances in the isolated ductus arteriosus of the fetal lamb. Pediatr Res 1972;6:231-238.
167. Fay FS, Nair P, Whalen WJ. Mechanism of oxygen induced contraction of ductus arteriosus. Adv Exp Med Biol 1977;78:123-134.
168. Coceani F, Hamilton NC, Labuc J, Olley PM. Cytochrome P450-linked monooxygenase: involvement in the lamb ductus arteriosus. Am J Physiol 1984;246:H640-H643.
169. Thébaud B, Michelakis ED, Wu XC et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation 2004;110:1372-1379.
170. Kajimoto H, Hashimoto K, Bonnet SN et al. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 2007;115:1777-1788.
171. Coceani F, Kelsey L, Seidlitz E. Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth. Can J Physiol Pharmacol 1992;70:1061-1064.
172. Coceani F, Kelsey L. Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol 1991;69:218-221.
173. Takahashi Y, Roman C, Chemtob S et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol 2000;278:R1496-R1505.
174. Clyman RI, Mauray F, Roman C, Rudolph AM. PGE2 is a more potent vasodilator of the lamb ductus arteriosus than is either PGI2 or 6 keto PGF1alpha. Prostaglandins 1978;16:259-264.
175. Clyman RI, Mauray F, Roman C, Rudolph AM, Heymann MA. Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs. J Pediatr 1980;97:455-461.
176. Clyman RI, Heymann MA, Rudolph AM. Ductus arteriosus responses to prostaglandin E1 at high and low oxygen concentrations. Prostaglandins 1977;13: 219-223.
177. Clyman RI, Mauray F, Heymann MA, Rudolph AM. Ductus arteriosus: developmental response to oxygen and indomethacin. Prostaglandins 1978;15:993-998.
178. Clyman RI, Mauray F, Roman C et al. Effects of antenatal glucocorticoid administration on ductus arteriosus of preterm lambs. Am J Physiol 1981;241:H415-H420.
179. Clyman RI, Waleh N, Black SM, Riemer RK, Mauray F, Chen YQ. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatr Res 1998;43:633-644.
180. Momma K, Toyono M. The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 1999;46:311-315.
181. Mentzer RM Jr, Ely SW, Lasley RD, Mainwaring RD, Wright EM Jr, Berne RM. Hormonal role of adenosine in maintaining patency of the ductus arteriosus in fetal lambs. Ann Surg 1985;202:223-230.
182. Sawa R, Asakura H, Power GG. Changes in plasma adenosine during simulated birth of fetal sheep. J Appl Physiol 1991;70:1524-1528.
183. Alzamora-Castro V, Battilana G, Abigattas R, Sialer S. Patent ductus arteriosus and high altitude. Am J Cardiol 1960;5:761-763.
184. Penaloza D, Arias-Stella J, Sime F, Recavarren S, Marticorens E. The heart and pulmonary circulation in children at high altitudes. Physiological, anatomical and clinical observations. Pediatrics 1964;34:568-582.
185. Powell ML. Patent ductus arteriosus in premature infants. Med J Aust 1963;2:58-60.
186. Lucas A, Mitchell MD. Plasma-prostaglandins in preterm neonates before and after treatment for patient ductus arteriosus. Lancet 1978;ii:130-132.
187. Clyman RI, Brett C, Mauray F. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatrics 1980;66:725-729.
188. Seidner SR, Chen YQ, Oprysko PR et al. Combined prostaglandin and nitric oxide inhibition produces anatomic remodeling and closure of the ductus arteriosus in the premature newborn baboon. Pediatr Res 2001;50:365-373.
189. Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994;125:270-277.
190. Clyman RI, Roman C, Heymann MA, Mauray F. How a patent ductus arteriosus effects the premature lamb's ability to handle additional volume loads. Pediatr Res 1987;22:531-535.
191. Evans M. Assessment and support of the preterm circulation. Early Hum Dev 2006;82:803-810.
192. Kluckow M, Evans NJ. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child 2000;82:F188-F194.
193. Teitel DF, Sidi D, Chin T, Brett C, Heymann MA, Rudolph AM. Developmental changes in myocardial contractile reserve in the lamb. Pediatr Res 1985;19: 948-955.
194. Newnham JP, Marshall CL, Padbury JF, Lam RW, Hobel CJ, Fisher DA. Fetal catecholamine release with preterm delivery. Amer J Obstet Gynecol 1984;149:888-893.
195. Osborn DA, Kluckow M, Evans N. Randomised trial of dobutamine vs dopamine in preterm infants with low systemic blood flow. J Pediatr 2002;140:183-191.
196. Paradisis M, Evans N, Kluckow M, Osborn D, McLachlan AJ. Pilot study of milrinone for low systemic blood flow in very preterm infants. J Pediatr 2006;148:306-313.
197. Kari MA, Raivio KO, Stenman UH, Voutilainen R. Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy. Pediatr Res 1996;40:319-324.
198. Seri I, Tan R, Evans J. Cardiovascular effects of hydrocortisone in preterm infants with pressor resistant hypotension. Pediatrics 2001;107:1070-1074.
199. Rudolph AM, Scarpelli EM, Golinko RJ, Gootman N. Hemodynamic basis for clinical manifestations of patent ductus arteriosus. Am Heart J 1964;68:447-458.
200. Fishman NH, Hof RB, Rudolph AM. Models of congenital heart disease in fetal lambs. Circulation 1978;58: 354-364.
201. Silverman NH, Lewis AB, Heymann MA, Rudolph AM. Echocardiographic assessment of ductus arteriosus shunt in premature infants. Circulation 1974;50:821-825.
202. Evans N, Moorcraft J. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child 1992;67:1169-1173.
203. Clyman RI, Jobe A, Heymann M et al. Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 1982;100:101-107.
204. Clyman RI, Mauray F, Heymann MA, Roman C. Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress. J Pediatr 1987;111:579-587.
205. Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008:23, CD006181.
206. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976;295: 530-533.
207. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982;306:506-510.
208. Van Bel F, Bartelds B, Teitel DF, Rudolph AM. Effect of indomethacin on cerebral blood flow and oxygenation in the normal and ventilated fetal lamb. Pediatr Res 1995;38:243-250.
209. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child 2003;88:F464-F466.
210. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2005;19: CD003481.
211. Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2007;18:CD003480.
212. Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV, Clyman RI. Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res 2005;58:1216-1221.
213. Villa E, Vanden Eynden F, Le Bret E, Folliguet T, La Borde F. Paediatric video-assisted thoracoscopic clipping of patent ductus arteriosus: experience in more than 700 cases, Eur J Cardiothorac Surg 2004;25:387-393.
214. Patterson DF, Detweiler DK. Hereditary transmission of patent ductus arteriosus in the dog. Am Heart J 1967;74:289-290.
215. Campbell M. The natural history of patent ductus arteriosus. Heart 1968;30:4-13.
216. Kleinman CS, Tabibian M, Starc TJ, Hsu DT, Gersony WM. Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. J Pediatr 2007;150:583-586.
217. Dajani AS, Taubert KA, Wilson W et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;96:358-366.
218. Awadallah SM, Kavey RE, Byrum CJ, Smith FC, Kveselis DA, Blackman MS. The changing pattern of infective endocarditis in childhood. Am J Cardiol 1991;68:90-94.
219. Balzer DT, Spray TL, McMullin D, Cottingham W, Canter CE. Endarteritis associated with a clinically silent patent ductus arteriosus. Am Heart J 1993;125: 1192-1193.
220. Schrader R, Kadel C. Persistierender Ductus arteriosus: istauch bei asymptomatischen Erwachsenen mit kleinem Ductus und genngen Shunt ein Verschluss indiziert? Z Kardiol 1993;82:563-567.
221. Thilen U, Astrom-Olsson K. Does the risk of infective endarteritis justify routine patent ductus arteriosus closure? Eur Heart J 1997;18:503-506.
222. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754.
223. Sullivan ID. Patent arterial duct: when should it be closed. Arch Dis Child 1998;78:285-287.
224. Portsmann W, Wierny L, Warneke H et al. Closure of the persistent ductus arteriosus: 62 cases treated without thoracotomy. Radiol Clin North Am 1971;9:203-218.
225. Rashkind WJ, Mullins CE, Hellenbrand WE, Tait MA. Non-surgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA occluder system. Circulation 1987;75:583-592.
226. Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol 1995;26: 1545-1548.
227. Paladini D, Palmieri S, Lamberti A, Teodoro A, Martinelli P, Nappi C. Characterization and natural history of ventricular septal defects in the fetus. Ultrasound Obstet Gynecol 2000;16:118-122.
228. Lister G, Walter TK, Versmold HT, Dallman PR, Rudolph AM. Oxygen delivery in lambs: cardiovascular and hematologic development. Am J Physiol 1979;237: H668-675.
229. Lees MH. Catecholamine metabolite excretion of infants with heart failure. J Pediatr 1966;69:259-265.
230. Lister G, Hellenbrand WE, Kleinman CS, Talner NS. Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. N Engl J Med 1982;306:502-506.
231. Teisseire BP, Ropars C, Vallez MO, Herigault RA, Nicolau C. Physiological effects of high-P50 erythrocyte transfusion on piglets. J Appl Physiol 1985;58:1810-1817.
232. Hait G, Corpus M, Lamarre FR, Yuan SH, Kypson J, Cheng G. Alteration of glucose and insulin metabolism in congenital heart disease. Circulation 1972;46:333-346.
233. Bland RD, Carlton DP, Scheerer RG, Cummings JJ, Chapman DL. Lung fluid balance in lambs before and after premature birth. J Clin Invest 1989;84:568-576.
234. Hoffman JI, Rudolph AM. The natural history of ventricular septal defects in infancy. Am J Cardiol 1965; 16:634-653.
235. Lin MH, Wang NK, Hung KL, Shen CT. Spontaneous closure of ventricular septal defects in the first year of life. J Formos Med Assoc 2001;100:539-542.
236. Hiraishi S, Agata Y, Nowatari M et al. Incidence and natural course of trabecular ventricular septal defect: twodimensional echocardiography and color Doppler flow imaging study. J Pediatr 1992;120:409-415.
237. Tomita H, Arakaki Y, Yagihara T, Echigo S. Incidence of spontaneous closure of outlet ventricular septal defect. Jpn Circ J 2001;65:364-366.
238. Mellins RB, Cheng G, Ellis K, Jameson AG, Malm JR, Blumenthal S. Ventricular septal defect with shunt from left ventricle to right atrium. Bacterial endocarditis as a complication. Br Heart J 1964;26:584-591.
239. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754.
240. Kleinman CS, Tabbian M, Starc TJ, Hsu DT, Gersony WM. Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. J Pediatr 2007;150:583-586.
241. Lun K, Li H, Leung MP et al. Analysis of indications for surgical closure of subarterial ventricular septal defect without associated aortic cusp prolapse and aortic regurgitation. Am J Cardiol 2001;87:1266-1270.
242. Hernández Morales G, Vázquez Antona CA, Muñoz Castellanos L et al. Aortic valve complications associated with subarterial infundibular ventricular septal defect. Echocardiograpic follow-up. Rev Esp Cardiol 2002;55: 936-942.
243. Bütter A, Duncan W, Weatherdon D, Hosking M, Cornel G. Aortic cusp prolapse in ventricular septal defect and its association with aortic regurgitation: appropriate timing of surgical repair and outcomes. Can J Cardiol 1998;14: 833-840.
244. Hoffman JIE, Rudolph AM, Danilowicz D. Left to right atrial shunts in infants. Am J Cardiol 1972;30:868-875.
245. Douglas JE, Rembert JC, Sealy WC, Greenfield JC. Factors affecting shunting in experimental atrial septal defect in dogs. Circ Res 1969;24:493-505.
246. Levin AR, Spach MS, Boineau JP, Canent RV Jr, Capp MP, Jewett PH. Atrial pressure-flow dynamics in atrial septal defects (secundum type). Circulation 1968;37: 476-488.
247. Weidman WH, Swan HJ, Dushane JW, Wood EH. A hemodynamic study of atrial septal defect and associated anomalies involving the atrial septum. J Lab Clin Med 1957;50:165-185.
248. Bolens M, Friedli B. Sinus node function and conduction system before and after surgery for secundum atrial septal defect: an electrophysiologic study. Am J Cardiol 1984;53:1415-1420.
249. Diab KA, Cao QLK, Bacha EA, Hijazi ZM. Device closure of atrial septal defects with the Amplatzer septal occluder: safety and outcome in infants. J Thorac Cardiovasc Surg 2007;134:960-966.
250. King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery 1974;75:383-388.
251. Shah D, Azhar M, Oakley CM, Cleland JG, Nihoyannopoulos P. Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J 1994;71:219-223.
252. Sievert H, Fischer E, Heinisch C, Majunke N, Roemer A, Wunderlich N. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience. Circulation 2007;116:1701-1706.
253. Sievert H, Taaffe M. Patent foramen ovale: the jury is still out. Eur Heart J 2004;25:361-362.
254. Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020-1024.
255. Mas J-L, Arquizan C, Lamy C et al. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. N Eng J Med 2001;345:1740-1746.
256. Domitrz I, Mieszkowskii J, Kaminska A. Relationship beween migraine and patent foramen ovale: a study of 121 patients with migraine. Headache 2007;47:1311-1318.
257. Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: a new therapy for migraine. Catheter Cardiovasc Interv 2007;69:277-284.
258. Tobis JM, Azarbal B. Does patent foramen ovale promote cryptogenic stroke and migraine headache? Tex Heart Inst J 2005;32:362-365.
259. Huggon IC, Cook AC, Smeeton NC, Magee AG, Sharland GK. Atrioventricular septal defects diagnosed in fetal life: associated cardiac and extra-cardiac abnormalities and outcome. J Am Coll Cardiol 2000;36:593-601.
260. Allan LD. Atrioventricular septal defect in the fetus. Am J Obstet Gynecol 1999;181:1250-1253.
261. Fesslova V, Villa L, Nava S, Boschetto C, Redaelli C, Mannarino S. Spectrum and outcome of atrioventricular septal defect in fetal life. Cardiol Young 2002;12:18-26.
262. Al-Hay AA, MacNeill SJ, Yacoub M, Shore DF, Shinebourne EA. Complete atrioventricular septal defect, Down syndrome, and surgical outcome: risk factors. Ann Thorac Surg 2003;75:412-421.
263. Kobayashi M, Takahashi Y, Ando M. Ideal timing of surgical repair of isolated complete atrioventricular septal defect. Interact Cardiovasc Thorac Surg 2007;6:24-26.
264. Rastelli GC, Kirklin JW, Titus JL. Anatomic observations on complete form of persistent common atrioventricular septal defects: its implications concerning conduction tissue disposition. Mayo Clin Proc 1966;41:296-308.
265. Macartney FJ, Zuberbuhler JR, Anderson RH. Morphologic considerations pertaining to recognition of atrial isomerism. Consequences for sequential chamber localisation. Br Heart J 1991;44:657-667.
266. Karl TR. Atrioventricular septal defect with Tetralogy of Fallot or double-outlet right ventricle: surgical considerations. Semin Thorac Cardiovasc Surg 1997;9:26-34.
267. Lange R, Guenther T, Busch R, Hess J, Schreiber C. The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg 2007;134:304-310.
268. van Son JA, Phoon CK, Silverman NH, Haas GS. Predicting feasibility of biventricular repair of rightdominant unbalanced atrioventricular canal. Ann Thorac Surg 1997;63:1657-1663.
269. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754.
270. Fernandes SM, Sanders SP, Khairy P et al. Morphology of bicuspid aortic valve in children and adolescents. J Am Coll Cardiol 2004;44:1648-1651.
271. Ciotti GR, Vlahos AP, Silverman NH. Morphology and function of the bicuspid aortic valve with and without coarctation of the aorta in the young. Am J Cardiol 2006;98:1096-1102.
272. Roberts WC, Ko JM. Frequency of unicuspid, bicuspid and tricuspid aortic valves by decade in adults having aortic valve replacement for isolated aortic stenosis. Circulation 2005;111:920-925.
273. Roos-Hesselink JW, Schölzel BE, Heijdra RJ et al. Aortic valve and aortic arch pathology after coarctation repair. Heart 2003;89:1074-1077.
274. Lewin MB, Otto CM. The bicuspid aortic valve. Adverse outcomes from infancy to old age. Circulation 2005; 111:832-834.
275. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002;106:900-904.
276. Oliver JM, Gonzalez A, Gallego P, Sanchez-Recalde A, Benito F, Mesa JM. Discrete subaortic stenosis in adults: increased prevalence and slow rate of progression of the obstruction and aortic regurgitation. J Am Coll Cardiol 2001;38:835-842.
277. Gersony WM. Natural history of discrete subvalvar aortic stenosis: management implications. J Am Coll Cardiol 2001;38:843-884.
278. Hallidie-Smith KA, Karas S. Cardiac anomalies in Williams-Beuren syndrome. Arch Dis Child 1988;63: 809-813.
279. McBride KL, Pignatelli R, Lewin M et al. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am J Med Genet A 2005; 134:180-186.
280. Martin LJ, Ramachandran V, Cripe LH et al. Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations. Hum Genet 2007;121:275-284.
281. Garg V, Muth AN, Ransom JF et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437: 270-274.
282. Garcia RE, Friedman WF, Kaback MM, Rowe RD. Idiopathic hypercalcemia and supravalvular aortic stenosis. Documentation of a new syndrome. N Engl J Med 1964;271:117-120.
283. Hornberger LK, Sanders SP, Rein AJ, Spevak PJ, Parness IA, Colan SD. Left heart obstructive lesions and left ventricular growth in midtrimester fetus. A longitudinal study. Circulation 1995;92:1531-1538.
284. Axt-Fliedner R, Kreiselmaier P, Schwarze A, Krapp M, Gembruch U. Development of hypoplastic left heart syndrome after diagnosis of aortic stenosis in the first trimester by early echocardiography. Ultrasound Obstet Gynecol 2006;28:106-109.
285. Makikallio K, McElhinney DB, Levine JC et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation 2006;113:1401-1405.
286. Fishman NH, Hof RB, Rudolph AM. Models of congenital heart disease in fetal lambs. Circulation 1978; 58:354-364.
287. Eghtesady P, Michelfelder E, Altaye M, Ballard E, Hirsh R, Beekman RH III. Revisiting animal models of aortic stenosis in the early gestation fetus. Ann Thorac Surg 2007;83:631-639.
288. Rhodes LA, Colan SD, Perry SB, Jonas RA, Sanders SP. Predictors of survival in neonates with critical aortic stenosis. Circulation 1991;84:2325-2335.
289. Erratum Circulation 1995;92:2005.
290. Colan SD, McElhinney DB, Crawford EC, Keane JF, Lock JE. Validation and re-evaluation of a discriminant model predicting anatomic suitability for biventricular repair in neonates with aortic stenosis. J Am Coll Cardiol 2006;47:1858-1865.
291. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 1951;41:1-29.
292. Agnoletti G, Raisky O, Boudjemline Y et al. Neonatal surgical aortic commissurotomy: predictors of outcome and long-term results. Ann Thorac Surg 2006;82:1592-1593.
293. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116: 1736-1754.
294. Favaloro R, Stutzbach P, Gomez C, Machain A, Casabe H. Feasibility of the Ross procedure: its relationship with the bicuspid aortic valve. J Heart Valve Dis 2002; 11:375-382.
295. Lev M. Pathologic anatomy and interrelationship of hypoplasia of the aortic tract complex. Lab Invest 1952;1:61-70.
296. Noonan JA, Nadas AS. The hypoplastic left heart syndrome: an analysis of 101 cases. Pediatr Clin North Am 1958;5:1029-1056.
297. Bharati S, Lev M. The surgical anatomy of hypoplasia of aortic tract complex. J Thorac Cardiovasc Surg 1984;88: 97-101.
298. Roberts WC, Perry LW, Chandra RS, Myers GE, Shapiro SR, Scott LP. Aortic valve atresia: a new classification based on necropsy study of 73 cases. Am J Cardiol 1976;37:753-756.
299. Cook AC. The phenotype during fetal develoment. In: Anderson RH, Smith AC, Pizzo M, eds. Hypoplastic Left Heart Syndrome. Singapore: Springer-Verlag, 2005.
300. Sauer U, Gittenberger-de Groot AC, Geishauer M, Babic R, Buhlmeyer K. Coronary arteries in the hypoplastic left heart syndrome. Histopathologic and histometrical studies and implications for surgery. Circulation 1989; 80:I168-I176.
301. Freedom RM, Culham JA, Rowe RD. Aortic atresia with normal left ventricle: distinctive angiocardiographic findings. Cath Cardiovasc Diagn 1977;3:283-295.
302. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable. J Am Coll Cardiol 2004;44:138-143.
303. Hinton RB Jr, Martin LJ, Tabangin ME, Mazwi ML, Cripe LH, Benson DW. Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol 2007;50:1590-1595.
304. Olson EM. A decade of discoveries in cardiac biology. Nat Med 2004;10:467-474.
305. Harh JY, Paul MH, Gallen WJ, Friedberg DZ, Kaplan S. Experimental production of hypoplastic left heart syndrome in the chick embryo. Am J Cardiol 1973;31:51-56.
306. Schall SA, Dalldorf FG. Premature closure of the foramen ovale and hypoplasia of the left heart. Int J Cardiol 1984;5:103-107.
307. Fishman NH, Hof RB, Rudolph AM. Models of congenital heart disease in fetal lambs. Circulation 1978; 58:354-364.
308. Eghteshady P, Michelfelder E, Altaye M, Ballard E, Hirsh R, Beekman RH III. Revisiting animal models of aortic stenosis in the early gestation fetus. Ann Thorac Surg 2007;83:631-639.
309. Hornberger LK, Sanders SP, Rein AJ, Spevak PJ, Parness IA, Colan SD. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation 1995;92:1531-1538.
310. Makikallio K, McElhinney DB, Levine JC et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention. Circulation 2006;113:1401-1405.
311. Maxwell D, Allan L, Tynan MJ. Balloon dilatation of the aortic valve in the fetus: a report of two cases. Br Heart J 1991;65:256-258.
312. Tworetzky W, Wilkins-Haug L, Jennings RW et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome. Candidate selection, technique, and results of successful intervention. Circulation 2004;110:2125-2131.
313. Axt-Fliedner R, Kreiselmaier P, Schwarze A, Krapp M, Gembruch U. Development of hypoplastic left heart syndrome after diagnosis of aortic stenosis in the first trimester by early echocardiography. Ultrasound Obstet Gynecol 2006;28:106-109.
314. Sharland GK, Chita SK, Fagg NL et al. Left ventricular dysfunction in the fetus: relation to aortic valve anomalies and endocardial fibroelastosis. Br Heart J 1991; 66:419-424.
315. Ursell PC, Neill CA, Anderson RH, Ho SY, Becker AE, Gerlis LM. Endocardial fibroelastosis and hypoplasia of the left ventricle in neonates without significant aortic stenosis. Br Heart J 1984;51:492-497.
316. Kuehl KS, Loffredo CA. A cluster of hypoplastic left heart malformation in Baltimore, Maryland. Pediatr Cardiol 2006;27:25-31.
317. Better DJ, Apfel HD, Zidere V, Allan LD. Pattern of pulmonary venous blood flow in the hypoplastic left heart syndrome in the fetus. Heart 1999;81:646-649.
318. Taketazu M, Barrea C, Smallhorn JF, Wilson GJ, Hornberger LK. Intrauterine pulmonary venous flow and restrictive foramen ovale in fetal hypoplastic left heart syndrome. J Am Coll Cardiol 2004;43:1902-1907.
319. Hutchins GM. Coarctation of the aorta explained as a branch-point of the ductus arteriosus. Am J Pathol 1971;63:203-214.
320. Leake RD, Strimling B, Emmanouilides GC. Intrauterine cardiac failure with hydrops fetalis. Case report in a twin with the hypoplastic left heart syndrome and review of the literature. Clin Pediatr 1973;12:649-651.
321. Sahn DJ, Shenker L, Reed KL, Sobonya R, Anderson R. Prenatal ultrasound diagnosis of hypoplastic left heart syndrome in utero associated wth hydrops fetalis. Am Heart J 1982;104:1368-1372.
322. Schmider A, Henrich W, Dähnert I, Dudenhausen JW. Prenatal therapy of non-immunologic hydrops fetalis caused by severe aortic stenosis. Ultrasound Obstet Gynecol 2000;16:275-278.
323. Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics 2000;105: 1082-1089.
324. Ikle L, Hale K, Fashaw L, Boucek M, Rosenberg AA. Developmental outcome of patients with hypoplastic left heart syndrome treated with heart transplantation. J Pediatr 2003;142:20-25.
325. Yang SS, Chen YC, Brough AJ, Bernstein J. Correlation of head circumference and crown-rump length in newborn infants. A potential indicator of congenital maldevelopment. Biol Neonate 1975;27:308-317.
326. Rosenthal GL. Patterns of prenatal growth among infants with cardiovascular malformations: possible fetal hemodynamic effects. Am J Epidemiol 1996;143:505-513.
327. Manzar S, Nair A, Pai MG, Al-Khusaiby SM. Head size at birth in neonates with transposition of great arteries and hypoplastic left heart syndrome. Saudi Med J 2005; 26:453-456.
328. Donofrio MT, Bremer YA, Schieken RM et al. Autoregulation of cerebral blood flow in fetuses with congenital heart disease: the brain sparing effect. Pediatr Cardiol 2003;24:436-443.
329. Kaltman JR, Di H, Tian Z, Rychik J. Impact of congenital heart disease on cerebrovascular blood flow dynamics in the fetus. Ultrasound Obstet Gynecol 2005;25:32-36.
330. Papile L, Rudolph AM, Heymann MA. Autoregulation of cerebral blood flow in the preterm fetal lamb. Pediatr Res 1985;19:159-161.
331. Hinton RB, Andelfinger G, Sekar P, Hinton AC, Gendron RL, Michelfelder EC, Robitaille Y, Benson DW. Prenatal head growth and white matter injury in hypoplastic left heart syndrome. Pediatr Res 2008;64:364-369.
332. Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol 1999;34: 554-560.
333. Maeda K, Yamaki S, Kado H, Asou T, Murakami A, Takamoto S. Hypoplasia of the small pulmonary arteries in hypoplastic left heart syndrome with restrictive atrial septal defect. Circulation 2004;110(suppl 1):139-146.
334. Glatz JA, Tabbutt S, Gaynor JM et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg 2007;84:1633-1638.
335. Rychik J, Gullquist SD, Jacobs ML, Norwood WI. Doppler echocardiographic analysis of flow in the ductus arteriosus of infants with hypoplastic left heart syndrome: relationship of flow patterns to systemic oxygenation and size of interatrial communication. J Am Soc Echocardiogr 1996;9:166-173.
336. Shillingford AJ, Ittenbach RF, Marino BS et al. Aortic morphometry and microcephaly in hypoplastic left heart syndrome. Cardiol Young 2007;17:189-195.
337. Norwood WI, Lang P, Casteneda AR, Campbell DN. Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1981;82:511-519.
338. Park SC, Zuberbuhler JR, Neches WH, Lenox CC, Zoltun RA. A new atrial septostomy technique. Cathet Cardiovasc Diagn 1975;1:195-201.
339. Ruiz CE, Gamra H, Zhang HP, García EJ, Boucek MM. Brief report: stenting of the ductus arteriosus as a bridge to cardiac transplantation in infants with the hypoplastic left-heart syndrome. N Engl J Med 1993;328:1605-1608.
340. Assad RS, Zamith MM, Silva MF et al. A novel adjustable pulmonary artery banding system for hypoplastic left heart syndrome. Ann Thorac Surg 2007;84:2081-2084.
341. Michel-Behnke I, Akintuerk H, Marquardt I et al. Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart 2003;89:645-650.
342. Hoffman GM, Tweddell JS, Ghanayem NS et al. Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the Norwood procedure. J Thorac Cardiovasc Surg 2004; 127:738-745.
343. Sano S, Ishino K, Kawada M et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2003;126:504-509.
344. Ghanayem NS, Jaquiss RD, Cava JR et al. Right ventricleto-pulmonary artery conduit versus Blalock-Taussig shunt: a hemodynamic comparison. Ann Thorac Surg 2006;82:1603-1609.
345. Kussman BD, Gauvreau K, DiNardo JA et al. Cerebral perfusion and oxygenation after the Norwood procedure: comparison of right ventricle-pulmonary artery conduit with modified Blalock-Taussig shunt. J Thorac Cardiovasc Surg 2007;133:648-655.
346. Rosenberg HS. Coarctation of the aorta: morphology and pathogenetic considerations. Perspect Pediatr Pathol 1973;1:339-368.
347. Angelini A, Allan LD, Anderson RH, Crawford DC, Chita SK, Ho SY. Measurements of the dimensions of the aortic and pulmonary pathways in the human fetus: a correlative echocardiographic and morphometric study. Br Heart J 1988;60:221-226.
348. Hornberger LK, Weintraub RG, Pesonen E et al. Echocardiographic study of the morphology and growth of the aortic arch in the human fetus. Observations related to the prenatal diagnosis of coarctation. Circulation 1992; 66:741-747.
349. Celoria GC, Patton RB. Congenital absence of the aortic arch. Am Heart J 1959;58:407-413.
350. Rudolph AM, Heymann MA, Spitznas U. Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol 1972;30:514-525.
351. Towbin JA, McQuinn TC. Gridlock: a model for coarctation of the aorta? Nat Med 1995;1:1141-1142.
352. Hutchins G. Coarctation of the aorta explained as a branch point of the ductus arteriosus. Am J Pathol 1971;63:203-214.
353. Allan LD, Chita SK, Anderson RH, Fagg N, Crawford DC, Tynan MJ. Coarctation of the aorta in prenatal life: an echocardiographic, anatomical, and functional study. Br Heart J 1988;59:356-60.
354. Hornung TS, Heads A, Hunter AS. Right ventricular dilatation in the fetus: a study of associated features and outcome. Pediatr Cardiol 2001;22:215-217.
355. Stos B, Le Bidois J, Fermont L, Bonnet D. Is antenatal diagnosis of coarctation of the aorta possible? Arch Mal Coeur 2007;100:428-432.
356. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000;117:260-267.
357. Weil MH, Tang W. Management of acidosis: the role of buffer agents. Crit Care 1997;1:51-52.
358. Delis KT, Gloviczki P. Middle aortic syndrome: from presentation to contemporary open surgical endovascular treatment. Perspect Vasc Surg Endovasc Ther 2005;17:187-203.
359. Konstantinov IE, Karamlou T, Blackstone EH et al. Truncus arteriosus associated with interrupted aortic arch in 50 neonates: a Congenital Heart Surgeons Society study. Ann Thorac Surg 2006;81:214-222.
360. Younoszai AK, Reddy VM, Hanley FL, Brook MM. Intermediate term follow-up of the end-to-side aortic anastomosis for coarctation of the aorta. Ann Thorac Surg 2002;74:1631-1634.
361. Forbes TJ, Garekar S, Amin Z et al. Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Intervent 2007;70:276-285.
362. Forbes TJ, Moore P, Pedra CA et al. Intermediate followup following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Intervent 2007;70:569-577.
363. Rao PS, Galal O, Smith PA, Wilson AD. Five-to nineyear follow-up results of balloon angioplasty of native aortic coarctation in infants and children. J Am Coll Cardiol 1996;27:462-470.
364. Ewert P, Peters B, Nagdyman N, Miera O, Kühne T, Berger F. Early and mid-term results with the Growth Stent: a possible concept for transcatheter treatment of aortic coarctation from infancy to adulthood by stent implantation? Catheter Cardiovasc Intervent 2008;71: 120-126.
365. Rouine-Rapp K, Mello DM, Hanley FL, Mohan Reddy V, Soifer S. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatr Crit Care Med 2003;4:327-332.
366. Choy M, Rocchini AP, Beekman RH et al. Paradoxical hypertension after repair of coarctation of the aorta in children: balloon angioplasty versus surgical repair. Circulation 1987;75:1186-1191.
367. Hashemzadeh K, Hashemzadeh S, Kakaei F. Repair of coarctation in adults: the fate of hypertension. Asian Cardiovasc Thorac Ann 2008;16:11-15.
368. O'Sullivan JJ, Derrick G, Darnell R. Prevalence of hypertension in children after early repair of coarctation of the aorta: a cohort study using casual and 24 hour blood pressure measurement. Heart 2002;88:163-166.
369. Gardiner HM, Celermajer DS, Sorensen KE et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation 1994;89:1745-1750.
370. Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754.
371. Karamlou T, Gurofsky R, Al Sukhni E et al. Factors associated with mortality and reoperation in 377 children with total anomalous pulmonary venous connection. Circulation 2007;115:1591-1598.
372. Haworth SG, Reid L. Structural study of pulmonary circulation and of heart in total anomalous pulmonary venous return in early infancy. Br Heart J 1977;39:80-92.
373. Shankargouda S, Krishnan U, Murali R, Shah MJ. Dysphonia: a frequently encountered symptom in the evaluation of infants with unobstructed supracardiac total anomalous pulmonary venous connection. Pediatr Cardiol 2000;21:458-460.
374. Hancock Friesen CL, Zurakowski D, Thiagarajan RR et al. Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg 2005;79:596-606.
375. Gaynor JW, Collins MH, Rychik J, Gaughan JP, Spray TL. Long-term outcome of infants with single ventricle and total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg 1999;117:506-501.
376. Kirshbom PM, Flynn TB, Clancy RR et al. Late neurodevelopmental outcome after repair of total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg 2005;129:1091-1097.
377. Bhat AH, Smith CJ, Hawker RE. Late aortic root dilatation in tetralogy of Fallot may be prevented by early repair in infancy. Pediatr Cardiol 2004;25:654-659.
378. Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation 2002;106:1374-1378.
379. Kim WH, Seo JW, Kim SJ, Song J, Lee J, Na CY. Aortic dissection late after repair of tetralogy of Fallot. Int J Cardiol 2005;101:515-516.
380. Niwa K. Aortic root dilatation in tetralogy of Fallot longterm after repair. Histology of the aorta in tetralogy of Fallot: evidence of intrinsic aortopathy. Int J Cardiol 2005;103:117-119.
381. Chong WY, Wong WH, Chiu CS, Cheung YF. Aortic root dilation and aortic elastic properties in children after repair of tetralogy of Fallot. Am J Cardiol 2006;97: 905-909.
382. Nørgaard MA, Alphonso N, Cochrane AD, Menahem S, Brizard CP, d'Udekem Y. Major aorto-pulmonary collateral arteries of patients with pulmonary atresia and ventricular septal defect are dilated bronchial arteries. Eur J Cardiothorac Surg 2006;29:682-687.
383. Hanley FL. MAPCAs, bronchials, monkeys and men. Eur J Cardiothorac Surg 2006;29:633-644.
384. Galindo A, Gutiérrez-Larraya F, Martínez JM et al. Prenatal diagnosis and outcome for fetuses with congenital absence of the pulmonary valve. Ultrasound Obstet Gynecol 2006;28:32-39.
385. Berg C, Thomsen Y, Geipel A, Germer U, Gembruch U. Reversed end-diastolic flow in the umbilical artery at 10-14 weeks of gestation is associated with absent pulmonary valve syndrome. Ultrasound Obstet Gynecol 2007;30:254-258.
386. Mjaatvedt CH, Nakaoka T, Moreno-Rodriguez R et al. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol 2001;238:97-109.
387. Zaffran S, Kelly RG, Meilhac SM, Buckingham ME, Brown NA. Right ventricular myocardium derives from the anterior heart field. Circ Res 2004;95:261-268.
388. Ward C, Stadt H, Hutson M, Kirby ML. Ablation of the secondary heart field leads to tetralogy of Fallot and pulmonary atresia. Dev Biol 2005;284:72-83.
389. Lakier JB, Stanger P, Heymann MA, Hoffman JIE, Rudolph AM. Tetralogy of Fallot with absent pulmonary valve: natural history and hemodynamic considerations. Circulation 1974;50:167-174.
390. Hornberger LK, Sanders SP, Sahn DJ et al. In utero pulmonary artery and aortic growth and potential for progression of pulmonary outflow tract obstruction in tetralogy of Fallot. J Am Coll Cardiol 1995;25:739-745.
391. Pepas LP, Savis A, Jones A, Sharland GK, Tulloh RM, Simpson JM. An echocardiographic study of tetralogy of Fallot in the fetus and infant. Cardiol Young 2003; 13:240-247.
392. Sun LS, Du F, Quaegebeur JM. Right ventricular infundibular beta-adrenoceptor complex in tetralogy of Fallot patients. Pediatr Res 1997;42:12-16.
393. Shaddy RE, Viney J, Judd VE, McGough EC. Continuous intravenous phenylephrine infusion for treatment of hypoxemic spells in tetralogy of Fallot. J Pediatr 1989; 114:468-470.
394. Rudolph AM, Nadas AS, Borges WH. Hematologic adjustments to cyanotic congenital heart disease. Pediatrics 1953;11:454-464.
395. Guntheroth WG, Morgan BC, Mullins GL. Physiologic studies of paroxysmal hyperpnea in cyanotic congenital heart disease. Circulation 1965;31:70-76.
396. Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Darragh RK. Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft. Ann Thorac Surg 2006;82:909-916.
397. Discigil B, Dearani JA, Puga FJ et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001;121:344-351.
398. Hsiao SM, Wu MH, Shih JC, Hsieh FJ. In utero progressive pulmonary stenosis successfully treated with transcatheter intervention after delivery. J Formos Med Assoc 2001;100:347-349.
399. Levin DL, Heymann MA, Rudolph AM. Morphological development of the pulmonary vascular bed in experimental pulmonic stenosis. Circulation 1979;59:179-182.
400. Tulzer G, Arzt W, Franklin RC, Loughna PV, Mair R, Gardiner HM. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 2002;360:1567-1568.
401. Jonker SS, Zhang L, Louey S, Giraud GD, Thornburg KL, Faber JJ. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol 2007;102:1130-1142.
402. Everett AW, Taylor RR, Sparrow MP. Increased protein synthesis during right ventricular hypertrophy following pulmonary stenosis in the dog. Recent Adv Stud Cardiac Struct Metab 1976;12:35-38.
403. Barbera A, Giraud GD, Reller MD, Maylie J, Morton MJ, Thornburg KL. Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am J Physiol 2000;279:R1157-R1164.
404. Akiba T, Becker AE. Disease of the left ventricle in pulmonary atresia with intact ventricular septum. The limiting factor for long-lasting successful surgical intervention? J Thorac Cardiovasc Surg 1994;108:1-8.
405. Beçu L, Somerville J, Gallo A. "Isolated" pulmonary valve stenosis as part of more widespread cardiovascular disease. Br Heart J 1976;38:472-482.
406. Mahony L, Clyman RI, Heymann MA. Decreased contractility of the ductus arteriosus in experimental pulmonic stenosis. Circulation 1984;70:695-699.
407. Danilowicz D, Hoffman JI, Rudolph AM. Serial studies of pulmonary stenosis in infancy and childhood. Br Heart J 1975;37:808-818.
408. Anand R, Mehta AV. Natural history of asymptomatic valvar pulmonary stenosis diagnosed in infancy. Clin Cardiol 1997;20:377-980.
409. Drossner DM, Mahle WT. A management strategy for mild valvar pulmonary stenosis. Pediatr Cardiol 2008;29: 649-652.
410. Arzt W, Tulzer G, Aigner M, Mair R, Hafner E. Invasive intrauterine treatment of pulmonary atresia/intact ventricular septum with heart failure. Ultrasound Obstet Gynecol 2003;21:186-188.
411. Peterson RE, Levi DS, Williams RJ, Lai WW, Sklansky MS, Drant S. Echocardiographic predictors of outcome in fetuses with pulmonary atresia with intact ventricular septum. J Am Coll Cardiol 2008;51:1299-1308.
412. Roman KS, Fouron JC, Nii M, Smallhorn JF, Chaturvedi R, Jaeggi ET. Determinants of outcome in fetal pulmonary valve stenosis or atresia with intact ventricular septum. Am J Cardiol 2007;99:699-703.
413. Rao PS, Galal O, Patnana M, Buck SH, Wilson AD. Results of three to 10 year follow up of balloon dilatation of the pulmonary valve. Heart 1998;80:591-595.
414. Poon LK, Menahem S. Pulmonary regurgitation after percutaneous balloon valvoplasty for isolated pulmonary valvar stenosis in childhood. Cardiol Young 2003;13: 444-450.
415. Garty Y, Veldtman G, Lee K, Benson L. Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol 2005;17: 318-322.
416. Khambadkone S, Coats L, Taylor A et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189-1197.
417. Wald RM, Tham EB, McCrindle BW et al. Outcome after prenatal diagnosis of tricuspid atresia: a multicenter experience. Am Heart J 2007;153:772-778.
418. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000;117:260-267.
419. Weil MH, Tang W. Management of acidosis: the role of buffer agents. Crit Care 1997;1:51-52.
420. Baker EJ, Jones OD, Joseph MC, Maisey MN, Tynan MJ. Radionuclide measurement of left ventricular ejection fraction in tricuspid atresia. Br Heart J 1984;52: 572-574.
421. Ho SY, Jackson M, Kilpatrick L, Smith A, Gerlis LM. Fibrous matrix of ventricular myocardium in tricuspid atresia compared with normal heart. A quantitative analysis. Circulation 1996;94:1642-1646.
422. Binotto MA, Higuchi M de L, Aiello VD. Left ventricular remodeling in hearts with tricuspid atresia: morphologic observations and possible basis for ventricular dysfunction after surgery. J Thorac Cardiovasc Surg 2003;126: 1026-1032.
423. Bernstein HS, Brook MM, Silverman NH, Bristow J. Development of pulmonary arteriovenous fistulae in children after cavopulmonary shunt. Circulation 1995;92(suppl II):309-314.
424. Marcelletti CF, Hanley FL, Mavroudis C et al. Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: a multicenter experience. J Thorac Cardiovasc Surg 2000;119:340-346.
425. Giardini A, Hager A, Napoleone CP, Picchio FM. Natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann Thorac Surg 2008;85:818-821.
426. Khairy P, Fernandes SM, Mayer JE Jr et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008;117:85-92.
427. Stellin G, Santini F, Thiene G et al. Pulmonary atresia, intact ventricular septum, and Ebstein anomaly of the tricuspid valve. Anatomic and surgical considerations. J Thorac Cardiovasc Surg 1993;106:255-261.
428. Inamura N, Taketazu M, Smallhorn JF, Hornberger LK. Left ventricular myocardial performance in the fetus with severe tricuspid valve disease and tricuspid insufficiency. Am J Perinatol 2005;22:91-97.
429. Hornberger LK, Sahn DJ, Kleinman CS, Copel JA, Reed KL. Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome. J Am Coll Cardiol 1991;17:167-173.
430. Sharland GK, Chita SK, Allan LD. Tricuspid valve dysplasia or displacement in intrauterine life. J Am Coll Cardiol 1991;17:944-949.
431. Pavlova M, Fouron JC, Drblik SP et al. Factors affecting the prognosis of Ebstein's anomaly during fetal life. Am Heart J 1998;135:1081-1085.
432. Wald RM, Adatia I, Van Arsdell GS, Hornberger LK. Relation of limiting ductal patency to survival in neonatal Ebstein's anomaly. Am J Cardiol 2005;96:851-856.
433. Celermajer DS, Bull C, Till JA et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 1994;23:170-176.
434. Hsieh YY, Lee CC, Chang CC, Tsai HD, Yeh LS, Tsai CH. Successful prenatal digoxin therapy for Ebstein's anomaly with hydrops fetalis. A case report. J Reprod Med 1998;43:710-712.
435. Reemtsen BL, Fagan BT, Wells WJ, Starnes VA. Current surgical therapy for Ebstein anomaly in neonates. J Thorac Cardiovasc Surg 2006;32:1285-1290.
436. Reddy VM, McElhinney DB, Brook MM, Silverman NH, Stanger P, Hanley FL. Repair of congenital tricuspid valve abnormalities with artificial chordae tendineae. Ann Thorac Surg 1998;66:172-176.
437. Quinonez LG, Dearani JA, Puga FJ et al. Results of the 1.5-ventricle repair for Ebstein anomaly and the failing right ventricle. J Thorac Cardiovasc Surg 2007;133: 1303-1310.
438. Marianeschi SM, McElhinney DB, Reddy VM, Silverman NH, Hanley FL. Alternative approach to the repair of Ebstein's malformation: intracardiac repair with ventricular unloading. Ann Thorac Surg 1998;66:1546-1550.
439. Roofthooft MT, Bergman KA, Waterbolk TW, Ebels T, Bartelds B, Berger RM. Persistent pulmonary hypertension of the newborn with transposition of the great arteries. Ann Thorac Surg 2007;83:1446-1450.
440. Digilio MC, Casey B, Toscano A et al. Complete transposition of the great arteries. Patterns of congenital heart disease in familial precurrence. Circulation 2001;104: 2809-2814.
441. Selamet Tierney ES, Marans Z, Rutkin MB, Chung WK. Variants of the CFC1 gene in patients with laterality defects associated with congenital cardiac disease. Cardiol Young 2007;17:268-274.
442. Goldmuntz E, Bamford R, Karkera JD, dela Cruz J, Roessler E, Muenke M. CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet 2002;70:776-780.
443. Rudolph AM. Aortopulmonary transposition in the fetus. Speculation on pathophysiology and therapy. Pediatr Res 2007;61:375-380.
444. Maeno YV, Kamenir SA, Sinclair B, van der Velde ME, Smallhorn JF, Hornberger LK. Prenatal features of ductus arteriosus constriction and restrictive foramen ovale in D-transposition of the great arteries. Circulation 1999;99:1209-1214.
445. Jouannic JM, Gavard L, Fermont L et al. Sensitivity and specificity of prenatal features of physiological shunts to predict neonatal clinical status in transposition of the great arteries. Circulation 2004;110:1743-1746.
446. Jouannic JM, Benachi A, Bonnet D et al. Middle cerebral artery Doppler in fetuses with transposition of the great arteries. Ultrasound Obstet Gynecol 2002;20: 122-124.
447. Rosenthal GL. Patterns of prenatal growth among infants with cardiovascular malformations: possible fetal hemodynamic effects. Am J Epidemiol 1996;143:505-513.
448. Manzar S, Nair AK, Pal MG, Al-Khusaiby SM. Head size at birth in neonates with transposition of great arteries and hypoplastic left heart syndrome. Saudi Med J 2005;26:453-456.
449. Auld PA, Rudolph AM, Golinko RJ. Factors affecting bronchial collateral flow in the dog. Am J Physiol 1959;197:617-623.
450. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000;117:260-267.
451. Weil MH, Tang W. Management of acidosis: the role of buffer agents. Crit Care 1997;1:51-52.
452. Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries. JAMA 1966; 196:991-992.
453. Park SC, Zuberbuhler JR, Neches WH, Lenox CC, Zoltun RA. A new atrial septostomy technique. Cathet Cardiovasc Diagn 1975;1:195-201.
454. Mustard WT, Keith JD, Trusler GA, Fowler R, Kidd L. The surgical management of transposition of the great vessels. J Thorac Cardiovasc Surg 1964;48:953-958.
455. Senning A. Correction of the transposition of the great arteries. Ann Surg 1975;182:287-292.
456. Hörer J, Herrmann F, Schreiber C et al. How well are patients doing up to 30 years after a Mustard operation? Thorac Cardiovasc Surg 2007;55:359-364.
457. Doughan AR, McMonnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol 2007;99:704-706.
458. Jatene AD, Fontes VF, Souza LC, Paulista PP, Neto CA, Sousa JE. Anatomic correction of transposition of the great arteries. J Thorac Cardiovasc Surg 1982;83:20-26.
459. Kondo C, Nakazawa M, Momma K, Kusakabe K. Sympathetic denervation and reinnervation after arterial switch operation for complete transposition. Circulation 1998;97:2414-2419.
460. Raisky O, Bergoend E, Agnoletti G et al. Late coronary artery lesions after neonatal arterial switch operation: results of surgical coronary revascularization. Eur J Cardiothorac Surg 2007;31:894-898.
461. Bove T, De Meulder F, Vandenplas G et al. Midterm assessment of the reconstructed arteries after the arterial switch operation. Ann Thorac Surg 2008;85:823-830.
462. Rastelli GC, Wallace RB, Ongley PA. Complete repair of tranposition of the great arteries with pulmonary stenosis. A review and report of a case corrected by using a new surgical technique. Circulation 1969;39:83-95.
463. Horer J, Schreiber C, Dworak E et al. Long-term results after the Rastelli repair for transposition of the great arteries. Ann Thorac Surg 2007;83:2169-2175.
464. Restivo A, Piacentini G, Placidi S et al. Cardiac outflow tract: a review of some embryogenetic aspects of the conotruncal region of the heart. Anat Rec A Discov Mol Cell Evol Biol 2006;288:936-943.
465. Schleiffarth JR, Person AD, Martinsen BJ et al. Wnt5a is required for cardiac outflow tract septation in mice. Pediatr Res 2007;61:386-391.
466. Momma K, Ando M, Matsuoka R. Truncus arteriosus communis associated with chromosome 22q11 deletion. J Am Coll Cardiol 1997;30:1067-1071.
467. Thompson LD, McElhinney DB, Reddy M, Petrossian E, Silverman NH, Hanley FL. Neonatal repair of truncus arteriosus: continuing improvement in outcomes. Ann Thorac Surg 2001;72:391-395.
468. Sierra J, Christenson JT, Lahlaidi NH, Beghetti M, Kalangos A. Right ventricular outflow tract reconstruction: what conduit to use? Homograft or Contegra? Ann Thorac Surg 2007;84:606-610.